Psychosis is often misunderstood, yet it is more common than many people realise. At MQ Mental Health Research, we are committed to improving understanding of mental health conditions through research and evidence. By breaking down what psychosis is, how it can present, and what support is available, we can help reduce stigma and support earlier access to care.
What is psychosis?
Psychosis is not a diagnosis in itself. It is a term used to describe a group of symptoms that affect how a person experiences reality. When someone is experiencing psychosis, their thoughts, perceptions and beliefs can change in ways that make it difficult to distinguish what is real from what is not.
For the person going through it, these experiences can feel completely real and can often be frightening or confusing. Psychosis can also be distressing for friends, family and carers who may not understand what is happening.
Although it can feel overwhelming, it is important to recognise that help and support are available, and many people recover or learn to manage their symptoms over time.
How Childhood Trauma Shapes the Risk of Psychosis
Around one in ten children will experience psychotic symptoms, such as hearing voices or seeing things others don’t. Research has long suggested a link between early adversity, such as bullying or abuse, and the later development of conditions like schizophrenia, but the mechanisms behind this connection have remained poorly understood.
MQ Fellow Dr Helen Fisher and her team at King’s College London analysed data from three large longitudinal studies to identify the biological, psychological, and social pathways through which childhood trauma can lead to psychosis in young people.
Key findings included that children who developed post-traumatic stress symptoms following adversity were at heightened risk of psychosis, and that differences in gene regulation were observed between children with and without psychotic experiences. The study has since informed early intervention strategies, contributed to public resources including ChildLine, and is feeding into the MQ-funded IDEA consortium, which aims to improve early identification of adolescent depression internationally.
Can Folic Acid Help Prevent Schizophrenia?
Folic acid is already known to reduce the risk of serious conditions affecting the nervous system, such as spina bifida. There is also growing evidence that it may offer protective benefits for mental health, but until now, no research has established a clear biological link between prenatal folic acid exposure and reduced risk of psychosis.
MQ-funded researcher and MQ Fellow Dr Joshua Roffman and his team at Massachusetts General Hospital set out to find that evidence. Studying MRI scans from over 1,300 children born before, during, and after the US introduction of mandatory folic acid fortification in 1998, they found that children born after fortification showed delayed cortical thinning in the brain — a marker associated with reduced psychosis risk.
The findings provided the first biological evidence that prenatal folic acid exposure can alter brain development in ways that appear to protect against psychosis. The research has since contributed to a policy change in the UK, supporting the introduction of folic acid fortification of bread and wheat products.
What Happens in the Brain When Schizophrenia Begins?
Schizophrenia affects 1% of the population and often first arises during the teenage years — a period of significant brain reorganisation. Yet the specific biological mechanisms involved, and the genes responsible for them, have remained poorly understood.
MQ Fellow Dr Petra Vértes and her team at the University of Cambridge analysed brain scans from hundreds of healthy volunteers, people who had experienced psychosis, and those identified as being at risk. By cross-referencing these with the Allen Brain Atlas, a comprehensive map of gene activity across the entire brain, the team developed a novel method of linking brain imaging with gene expression data.
Key findings included that male and female brains develop differently during adolescence, with certain regions showing more pronounced changes in women that overlap with areas linked to depression. The study also identified a cluster of genes highly expressed in brain regions vulnerable to schizophrenia, including potential new drug targets. The methodological tools developed are now being applied to a range of other conditions, including autism, depression, and epilepsy.
How You Can Support Us
Donate
Donate towards the improvement and prevention of mental illness.
Fundraise
Raise money for mental health research by organising a fundraising event.
Subscribe
Keep up with latest updates in the world of mental health research.
The post Understanding Psychosis: Symptoms, Causes, Treatment and Support first appeared on MQ Mental Health Research.

